A major Gurgaon raid uncovered 262 suspected fake Mounjaro vials worth about Rs 70 lakh, arresting two people. Investigators now say part of the batch was routed to Hyderabad, where at least six injections reportedly reached a dealer. The alleged operation includes manufacturing from a Gurgaon flat using China-sourced materials and 3D-printed packaging, with probes into wider inter-city and online networks.
Gurugram authorities busted a counterfeit Mounjaro operation after police seized fake diabetes and weight-loss injections worth ₹70 lakh. The alleged mastermind, Avi Sharma, is accused of importing raw materials from China and producing the illicit drugs for profit. Investigators say clear differences in packaging and multiple typographical errors revealed the fakes.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Gurugram law enforcement has reportedly dismantled a counterfeit Mounjaro operation, placing two people in custody. Authorities say the ring imported raw materials from China and manufactured the injections at a private home, supplying illicit diabetes and obesity drugs. Eli Lilly issued a statement after the Gurugram drug racket was exposed, underscoring growing concerns about counterfeit GLP-1 medications.
Mounjaro sales are sliding across India as Novo Nordisk drives a price war for Ozempic and Wegovy and cheaper semaglutide generics gain traction. Eli Lilly says it’s seeing increased competition but remains confident in Mounjaro’s differentiated benefits for users. The shift highlights how rapidly GLP-1 therapy markets are being reshaped by pricing pressure.
India’s appetite for weight-loss injectables like Ozempic and Mounjaro is rising fast, with consumers seeking gradual weight reduction. But healthcare professionals are warning that the current regulatory and marketing environment is not keeping pace, increasing the risk of misuse and improper promotion. Calls are growing for stronger oversight to protect patients.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
